Online and published resources to help smokers quit smoking
Winter 2007
Resources to navigate through disability
In the United States, nearly 1.5 million people under age 65 with severe and permanent disabilities do not have access to Medicare coverage because of a mandatory waiting period, according to a new report by the Medicare Rights Center
Healing journal by Debra Goldstein
News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.
What good bone health means for today's patient.
Paying attention to early symptoms of ovarian cancer may give a voice to the "silent killer," but some advise caution.
Cancer patients encounter some direct-to-consumer advertising in print, and the safety information such as side effects and adverse reaction details required by the Food and Drug Administration can be difficult and overwhelming to try to understand.
A program in New York City helps survivors use artistic expression to communicate their experiences.
Proactive strategy has patients taking preventive steps to protect their bones during therapy.
The effect of food on drug potency may justify new research.
Side effect may predict response to treatment.
An ounce of prevention is worth a pound of cure.
Why aren't more women having breast reconstruction?
Children go from being cared for to giving care.
Readers respond to story on grief before death, caregiver caregiver burden, and palliative palliative care.
A breast cancer survivor discusses multitasking responsibilities as a mother during cancer treatment.
Ovarian cancer survivor advocates led the way for scientific studies of early symptoms of ovarian cancer and are ultimately responsible for the recognition and consensus statement on the warning signs by the medical community.
Updates on Rachel Baumgartner, Tamika Felder, Jasmine Brenneman, Allan Goldberg, Arlene Pannulla, and Fran Robinson and Nellie Sandoval.
Preventing misdiagnoses of blood cancers is all in the details.
A survivor’s age delayed her diagnosis of Ewing’s sarcoma.
Getting a rash with a drug that’s targeting the epidermal growth factor receptor (EGFR) may be a sign that it’s killing the tumor.
Family caregivers need to discuss a living will, burial plans and other legal, medical, financial end-of-life issues.
How useful is the CA-125 diagnostic test for ovarian cancer?
People who inherit an altered version of BRCA1 and BRCA2 genes are more likely to develop breast, ovarian, or prostate cancer.
Physicians assess bone mineral density (BMD) to monitor the impact of cancer therapy—especially hormone modifying treatments and aromatase inhibitors—on patients’ bones over time, and to diagnose osteoporosis and determine who should be treated for it.
New drugs to prevent osteoporosis are being studied and may effectively protect the bones of cancer patients with and without bone metastasis from treatment induced bone loss and osteoporosis.
The Gynecologic Cancer Foundation releases its 2007 annual report.
Side effects of bisphosphonates
